Metronomic treatment significantly enhanced cytotoxicity in palbociclib-resistant ER-positive breast cancer cell lines

被引：0
|
作者：
Sherif, N. [1 ]
Ilari, A. [1 ]
Cordani, N. [1 ]
Grassilli, E. [1 ]
Cazzaniga, M. E. [1 ]
Lavitrano, M. [1 ]
Cerrito, M. G. [1 ]
机构：
[1] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113825
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257 (PB-07
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [1] Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
    Kettner, Nicole M.
    Vijayaraghavan, Smruthi
    Durak, Merih Guray
    Bui, Tuyen
    Kohansal, Mehrnoosh
    Ha, Min Jin
    Liu, Bin
    Rao, Xiayu
    Wang, Jing
    Yi, Min
    Carey, Jason P. W.
    Chen, Xian
    Eckols, T. Kris
    Raghavendra, Akshara S.
    Ibrahim, Nuhad K.
    Karuturi, Meghan Sri
    Watowich, Stephanie S.
    Sahin, Aysegul
    Tweardy, David J.
    Hunt, Kelly K.
    Tripathy, Debu
    Keyomarsi, Khandan
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3996 - 4013
  • [2] Lasofoxifene alone or in combination with palbociclib as an effective treatment for therapy-resistant ER-positive metastatic breast cancer
    Laine, Muriel
    Kurleto, Justyna D.
    Greene, Marianne E.
    Phung, Linda
    Komm, Barry S.
    Greene, Geoffrey L.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] PALBOCICLIB: CDK4/6 INHIBITION IN THE TREATMENT OF ER-POSITIVE BREAST CANCER
    Owsley, J.
    Jimeno, A.
    Diamond, J. R.
    DRUGS OF TODAY, 2016, 52 (02) : 119 - 129
  • [4] Leptin Modulates the Response to Tamoxifen Treatment in ER-Positive Breast Cancer Cell Lines
    Yom, C. K.
    Han, W.
    Kim, S-W
    Kim, D. W.
    Kang, E.
    Noh, D-Y
    CANCER RESEARCH, 2011, 71
  • [5] Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib
    Wei, Hsiu-Chuan
    AIMS MATHEMATICS, 2020, 5 (04): : 3446 - 3455
  • [6] Palbociclib and letrozole for ER-positive, HER2-negative advanced breast cancer
    Abraham, Jame
    Mechcatie, Elizabeth
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (03): : 83 - 86
  • [7] Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
    Laine, Muriel
    Greene, Marianne E.
    Kurleto, Justyna D.
    Bozek, Grazyna
    Leng, Tiffany
    Huggins, Rosemary J.
    Komm, Barry S.
    Greene, Geoffrey L.
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [8] Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
    Laine, Muriel
    Fanning, Sean W.
    Chang, Ya-Fang
    Green, Bradley
    Greene, Marianne E.
    Komm, Barry
    Kurleto, Justyna D.
    Phung, Linda
    Greene, Geoffrey L.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [9] Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
    Muriel Lainé
    Sean W. Fanning
    Ya-Fang Chang
    Bradley Green
    Marianne E. Greene
    Barry Komm
    Justyna D. Kurleto
    Linda Phung
    Geoffrey L. Greene
    Breast Cancer Research, 23
  • [10] Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy
    Lypova, Nadiia
    Lanceta, Lilibeth
    Gipson, Alana
    Vega, Stephanie
    Garza-Morales, Rodolfo
    McMasters, Kelly M.
    Chesney, Jason
    Gomez-Gutierrez, Jorge G.
    Imbert-Fernandez, Yoannis
    CANCERS, 2019, 11 (05)
12345